|
1
|
Zhang KJ, Zhang BY, Zhang KP, Tang LM, Liu
SS, Zhu DM and Zhang DL: Clinicopathologic significance of slug
expression in human intrahepatic cholangiocarcinoma. World J
Gastroenterol. 16:2554–2557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao S, Wang J and Qin C: Blockade of
CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma
progression and metastasis via inactivation of canonical Wnt
pathway. J Exp Clin Cancer Res. 33:1032014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okuda K, Nakanuma Y and Miyazaki M:
Cholangiocarcinoma: Recent progress. Part 2: Molecular pathology
and treatment. J Gastroenterol Hepatol. 17:1056–1063. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Palmer WC and Patel T: Are common factors
involved in the pathogenesis of primary liver cancers? A
meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
J Hepatol. 57:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wybenga-Groot LE and McGlade CJ: RTK SLAP
down: The emerging role of Src-like adaptor protein as a key player
in receptor tyrosine kinase signaling. Cell Signal. 27:267–274.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kazi JU, Kabir NN and Rönnstrand L: Role
of SRC-like adaptor protein (SLAP) in immune and malignant cell
signaling. Cell Mol Life Sci. 72:2535–2544. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kazi JU, Agarwal S, Sun J, Bracco E and
Rönnstrand L: Src-like-adaptor protein (SLAP) differentially
regulates normal and oncogenic c-Kit signaling. J Cell Sci.
127:653–662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kazi JU and Rönnstrand L: Src-Like adaptor
protein (SLAP) binds to the receptor tyrosine kinase Flt3 and
modulates receptor stability and downstream signaling. PLoS One.
7:e535092012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang J, Sawasdikosol S, Chang JH and
Burakoff SJ: SLAP, a dimeric adapter protein, plays a functional
role in T cell receptor signaling. Proc Natl Acad Sci USA.
96:9775–9780. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo
H, Tian T, Ruan ZP, Kang XM, Wang J, et al: SDF-1/CXCR4 promotes
epithelial-mesenchymal transition and progression of colorectal
cancer by activation of the Wnt/β-catenin signaling pathway. Cancer
Lett. 354:417–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang F, Wan M, Xu Y, Li Z, Leng K, Kang
P, Cui Y and Jiang X: Long noncoding RNA PCAT1 regulates
extrahepatic cholangiocarcinoma progression via the
Wnt/β-catenin-signaling pathway. Biomed Pharmacother. 94:55–62.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Li YP, Paulson C, Shao JZ, Zhang
X, Wu M and Chen W: Wnt and the Wnt signaling pathway in bone
development and disease. Front Biosci (Landmark Ed). 19:379–407.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen P, Lee S, Lorang-Leins D, Trepel J
and Smart DK: SIRT2 interacts with β-catenin to inhibit Wnt
signaling output in response to radiation-induced stress. Mol
Cancer Res. 12:1244–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prakobwong S, Khoontawad J, Yongvanit P,
Pairojkul C, Hiraku Y, Sithithaworn P, Pinlaor P, Aggarwal BB and
Pinlaor S: Curcumin decreases cholangiocarcinogenesis in hamsters
by suppressing inflammation-mediated molecular events related to
multistep carcinogenesis. Int J Cancer. 129:88–100. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan Y, Liang H, Li T, Li M, Li R, Qin X
and Li S: The MMP-1, MMP-2, and MMP-9 gene polymorphisms and
susceptibility to bladder cancer: A meta-analysis. Tumour Biol.
35:3047–3052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao H, Yuan X, Jiang J, Wang P, Sun X,
Wang D and Zheng Q: Antimetastatic effects of licochalcone B on
human bladder carcinoma T24 by inhibition of matrix
metalloproteinases-9 and NF-kB activity. Basic Clin Pharmacol
Toxicol. 115:527–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blechacz B and Gores GJ:
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and
treatment. Hepatology. 48:308–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mansha M, Carlet M, Ploner C, Gruber G,
Wasim M, Wiegers GJ, Rainer J, Geley S and Kofler R: Functional
analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene
in acute lymphoblastic leukemia. Leuk Res. 34:529–534. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moharram SA, Chougule RA, Su X, Li T, Sun
J, Zhao H, Rönnstrand L and Kazi JU: Src-like adaptor protein 2
(SLAP2) binds to and inhibits FLT3 signaling. Oncotarget.
7:57770–57782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang GL, Song W, Zhou P, Fu QR, Lin CL,
Chen QX and Shen DY: Oncogenic retinoic acid receptor gamma
knockdown reverses multi-drug resistance of human colorectal cancer
via Wnt/β-catenin pathway. Cell Cycle. 16:685–692. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen W, Liang J, Huang L, Cai J, Lei Y,
Lai J, Liang L and Zhang K: Characterizing the activation of the
Wnt signaling pathway in hilar cholangiocarcinoma using a tissue
microarray approach. Eur J Histochem. 60:25362016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Zhang K, Wang J, Wu X, Liu X, Li
B, Zhu Y, Yu Y, Cheng Q, Hu Z, et al: Underexpression of LKB1 tumor
suppressor is associated with enhanced Wnt signaling and malignant
characteristics of human intrahepatic cholangiocarcinoma.
Oncotarget. 6:18905–18920. 2015.PubMed/NCBI
|
|
27
|
Boulter L, Guest RV, Kendall TJ, Wilson
DH, Wojtacha D, Robson AJ, Ridgway RA, Samuel K, Van Rooijen N,
Barry ST, et al: WNT signaling drives cholangiocarcinoma growth and
can be pharmacologically inhibited. J Clin Invest. 125:1269–1285.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loilome W, Bungkanjana P, Techasen A,
Namwat N, Yongvanit P, Puapairoj A, Khuntikeo N and Riggins GJ:
Activated macrophages promote Wnt/β-catenin signaling in
cholangiocarcinoma cells. Tumour Biol. 35:5357–5367. 2014.
View Article : Google Scholar : PubMed/NCBI
|
